300685 艾德生物
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)4.14018.53014.37216.32718.416
总资产报酬率 ROA (%)3.59016.37412.74414.58416.636
投入资产回报率 ROIC (%)3.84417.73813.89215.73917.948

边际利润分析
销售毛利率 (%)82.45982.59184.74783.96882.449
营业利润率 (%)37.66334.85126.41928.86934.157
息税前利润/营业总收入 (%)39.67532.48623.67725.77930.404
净利润/营业总收入 (%)32.70930.16222.98225.05831.382

收益指标分析
经营活动净收益/利润总额(%)96.021100.582108.654101.68862.944
价值变动净收益/利润总额(%)1.5643.560-0.168-0.6780.691
营业外收支净额/利润总额(%)-2.256-1.583-1.068-2.167-0.552

偿债能力分析
流动比率 (X)15.14211.5269.1809.28813.974
速动比率 (X)14.81211.3169.0039.12313.617
资产负债率 (%)14.15612.42510.72911.9689.158
带息债务/全部投入资本 (%)8.2534.3061.8282.7402.956
股东权益/带息债务 (%)1,101.8892,201.6385,293.1063,524.0473,255.050
股东权益/负债合计 (%)606.408704.842832.035735.583991.900
利息保障倍数 (X)13.956-17.830-9.614-10.407-8.527

营运能力分析
应收账款周转天数 (天)213.826176.012170.220168.117188.285
存货周转天数 (天)82.12861.89867.20166.30279.288